4.7 Article

Effects of vedolizumab in Japanese patients with Crohn's disease: a prospective, multicenter, randomized, placebo-controlled Phase 3 trial with exploratory analyses

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

Rapid Response to Vedolizumab Therapy in Biologic-Naive Patients With Inflammatory Bowel Diseases

Brian G. Feagan et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)

Article Gastroenterology & Hepatology

Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases

Joseph Meserve et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)

Article Pharmacology & Pharmacy

A Phase 1, Multiple-Dose Study of Vedolizumab in Japanese Patients With Ulcerative Colitis

Kiyonori Kobayashi et al.

JOURNAL OF CLINICAL PHARMACOLOGY (2019)

Article Gastroenterology & Hepatology

Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn's Disease

Mark Lowenberg et al.

GASTROENTEROLOGY (2019)

Article Gastroenterology & Hepatology

Endoscopic, Radiologic, and Histologic Healing With Vedolizumab in Patients With Active Crohn's Disease

Silvio Danese et al.

GASTROENTEROLOGY (2019)

Review Gastroenterology & Hepatology

ACG Clinical Guideline: Management of Crohn's Disease in Adults

Gary R. Lichtenstein et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2018)

Article Gastroenterology & Hepatology

Evidence to Support Monitoring of Vedolizumab Trough Concentrations in Patients With Inflammatory Bowel Diseases

Erwin Dreesen et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)

Article Gastroenterology & Hepatology

Fecal calprotectin is not superior to serum C-reactive protein or the Harvey-Bradshaw index in predicting postoperative endoscopic recurrence in Crohn's disease

Cristina Verdejo et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2018)

Article Gastroenterology & Hepatology

Clinical Practice Guidelines for the Use of Video Capsule Endoscopy

Robert A. Enns et al.

GASTROENTEROLOGY (2017)

Article Gastroenterology & Hepatology

Exposure-efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease

Maria Rosario et al.

JOURNAL OF CROHNS & COLITIS (2017)

Review Pharmacology & Pharmacy

A Review of the Clinical Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Vedolizumab

Maria Rosario et al.

CLINICAL PHARMACOKINETICS (2017)

Review Gastroenterology & Hepatology

Systematic review: the safety of vedolizumab for the treatment of inflammatory bowel disease

W. A. Bye et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)

Article Gastroenterology & Hepatology

The Real-World Effectiveness and Safety of Vedolizumab for Moderate-Severe Crohn's Disease: Results From the US VICTORY Consortium

Parambir S. Dulai et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)

Review Gastroenterology & Hepatology

An Overview of the Mechanism of Action of the Monoclonal Antibody Vedolizumab

Tim Wyant et al.

JOURNAL OF CROHNS & COLITIS (2016)

Article Medicine, General & Internal

Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease

B. G. Feagan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Review Gastroenterology & Hepatology

Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management

Giulia Roda et al.

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2016)

Review Gastroenterology & Hepatology

Changing epidemiological trends of inflammatory bowel disease in Asia

Wee Khoon Ng et al.

INTESTINAL RESEARCH (2016)

Article Gastroenterology & Hepatology

Population pharmacokinetics-pharmacodynamics of vedolizumab in patients with ulcerative colitis and Crohn's disease

M. Rosario et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)

Article Gastroenterology & Hepatology

Clinical characteristics and treatment of inflammatory bowel disease: A comparison of Eastern and Western perspectives

Soo Jung Park et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Article Medicine, General & Internal

Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

William J. Sandborn et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Review Health Care Sciences & Services

Clinical use of anti-TNF therapy and increased risk of infections

Tauseef Ali et al.

DRUG HEALTHCARE AND PATIENT SAFETY (2013)

Article Medicine, General & Internal

Brief report - Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis

BK Kleinschmidt-DeMasters et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)